Monday, October 26, 2020

Startup focused on B-cell therapies launched with $52M in Series A

After tackling two major research challenges, the founders of Be Biopharma are ready to announce their official launch along with a $52 million funding round. They are intent upon using the body’s B cells to treat a range of diseases. The Series A round was led by Atlas Venture and RA Capital Management. Joining in...

Nonprofit tests app for travelers to meet cross-border Covid-19 requirements

A volunteer uses CommonPass to board a flight from London to Newark. The CommonPass health pass allows travellers to securely share their Covid-19 status across international borders. Photo credit: CommonPass Most countries currently have restrictions in place barring non-essential travel, and health authorities recommend staying home. But for those who anticipate a trip across...

Why most hospitals could save millions by improving patient safety

The first wave of Covid-19 may gave subsided in some areas of the country, but in others it is growing and hospitals everywhere are continuing to face significant challenges. The American Hospital Association recently estimated that hospitals will incur at least $323.1 billion in losses through the end of this year due to Covid-19....

AppliedVR gets breakthrough device designation for VR to treat pain

AppliedVR received a breakthrough device designation for its VR system for treating chronic pain. Photo credit: AppliedVR A virtual reality program intended to treat fibromyalgia and chronic lower back pain received a breakthrough device designation from The Food and Drug Administration. AppliedVR, the Los Angeles-based startup developing it, said the designation was a milestone...

How Bind Benefits’ CEO will use $105M to upend the health insurance market

Customization is something that people are pursuing and adopting in every aspect of their life. One startup is betting this will extend to their consumption of health insurance as well. Bind Benefits, a personalized health plan provider that recently entered the fully insured market in Florida, has raised $105 million in a new funding...

Demand rises for single-use surgical technologies in the era of Covid-19

As the Covid-19 pandemic continues to unfold, it is clear that the virus has fundamentally impacted every aspect of life in the United States. The healthcare sector has had to completely reimagine much of what was once standard operating procedure. This has driven adoption of new tools in many areas of the life...

Technology can ease pandemic challenges faced by hospitals, ambulatory surgery centers

Hospitals and ambulatory surgery centers (ASCs) need elective procedures to be able to return to near pre-pandemic levels for both their patients as well as their hospital’s financial health, but the continued impact of the coronavirus pandemic complicates the issue in many geographies. The American Hospital Association (AHA) estimates that the country’s hospitals will...

Covid-19’s digital imperative for biopharma and medtech

therapeutics
The public health crisis of Covid-19 continues to cast a long shadow on business operations everywhere, including the biopharma industry. It is preventing sales reps from visiting doctors, delaying product launches and making them more complex to execute. It is also impacting clinical trials and underscoring the need for a more digital focused...

Using digital engagement to solve pain points along the patient journey: How to deliver better outcomes for patients and brands

There are numerous challenges that a patient commonly faces along the patient journey, starting with the provider’s decision to treat and the course of therapy prescribed for the patient. Be a part of this webinar on November 10th at 1pm ET/10am PT  and learn to examine how digital engagement can solve challenges for both...

Landmark FDA approval of antiviral drug as 1st COVID-19 treatment comes amid conflicting efficacy data

Red seal and imprint "FDA APPROVED" on white surface. FDA - Food and Drug Administration is a federal agency of the United States Department of Health and Human Services.
The FDA has approved remdesivir for the treatment of Covid-19, making it the first and only treatment for the disease caused by the new coronavirus. The green light from the agency comes just one week after a WHO report found that the drug wasn’t that effective in patients hospitalized with the illness. Manufactured by...
0FansLike
0FollowersFollow
- Advertisement -

Must Read